A citation-based method for searching scientific literature

Jan J Molenaar, Jan Koster, Danny A Zwijnenburg, Peter van Sluis, Linda J Valentijn, Ida van der Ploeg, Mohamed Hamdi, Johan van Nes, Bart A Westerman, Jennemiek van Arkel, Marli E Ebus, Franciska Haneveld, Arjan Lakeman, Linda Schild, Piet Molenaar, Peter Stroeken, Max M van Noesel, Ingrid Ora, Evan E Santo, Huib N Caron, Ellen M Westerhout, Rogier Versteeg. Nature 2012
Times Cited: 554







List of co-cited articles
801 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


The genetic landscape of high-risk neuroblastoma.
Trevor J Pugh, Olena Morozova, Edward F Attiyeh, Shahab Asgharzadeh, Jun S Wei, Daniel Auclair, Scott L Carter, Kristian Cibulskis, Megan Hanna, Adam Kiezun,[...]. Nat Genet 2013
607
33

Telomerase activation by genomic rearrangements in high-risk neuroblastoma.
Martin Peifer, Falk Hertwig, Frederik Roels, Daniel Dreidax, Moritz Gartlgruber, Roopika Menon, Andrea Krämer, Justin L Roncaioli, Frederik Sand, Johannes M Heuckmann,[...]. Nature 2015
266
26

Massive genomic rearrangement acquired in a single catastrophic event during cancer development.
Philip J Stephens, Chris D Greenman, Beiyuan Fu, Fengtang Yang, Graham R Bignell, Laura J Mudie, Erin D Pleasance, King Wai Lau, David Beare, Lucy A Stebbings,[...]. Cell 2011
24

Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations.
Tobias Rausch, David T W Jones, Marc Zapatka, Adrian M Stütz, Thomas Zichner, Joachim Weischenfeldt, Natalie Jäger, Marc Remke, David Shih, Paul A Northcott,[...]. Cell 2012
516
22

Chromothripsis from DNA damage in micronuclei.
Cheng-Zhong Zhang, Alexander Spektor, Hauke Cornils, Joshua M Francis, Emily K Jackson, Shiwei Liu, Matthew Meyerson, David Pellman. Nature 2015
503
19

Criteria for inference of chromothripsis in cancer genomes.
Jan O Korbel, Peter J Campbell. Cell 2013
286
19

Recent advances in neuroblastoma.
John M Maris. N Engl J Med 2010
18

TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.
Linda J Valentijn, Jan Koster, Danny A Zwijnenburg, Nancy E Hasselt, Peter van Sluis, Richard Volckmann, Max M van Noesel, Rani E George, Godelieve A M Tytgat, Jan J Molenaar,[...]. Nat Genet 2015
184
18

Association of age at diagnosis and genetic mutations in patients with neuroblastoma.
Nai-Kong V Cheung, Jinghui Zhang, Charles Lu, Matthew Parker, Armita Bahrami, Satish K Tickoo, Adriana Heguy, Alberto S Pappo, Sara Federico, James Dalton,[...]. JAMA 2012
241
17

DNA breaks and chromosome pulverization from errors in mitosis.
Karen Crasta, Neil J Ganem, Regina Dagher, Alexandra B Lantermann, Elena V Ivanova, Yunfeng Pan, Luigi Nezi, Alexei Protopopov, Dipanjan Chowdhury, David Pellman. Nature 2012
693
15

The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
Susan L Cohn, Andrew D J Pearson, Wendy B London, Tom Monclair, Peter F Ambros, Garrett M Brodeur, Andreas Faldum, Barbara Hero, Tomoko Iehara, David Machin,[...]. J Clin Oncol 2009
894
15

Identification of ALK as a major familial neuroblastoma predisposition gene.
Yaël P Mossé, Marci Laudenslager, Luca Longo, Kristina A Cole, Andrew Wood, Edward F Attiyeh, Michael J Laquaglia, Rachel Sennett, Jill E Lynch, Patrizia Perri,[...]. Nature 2008
804
15

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.
Mark Sausen, Rebecca J Leary, Siân Jones, Jian Wu, C Patrick Reynolds, Xueyuan Liu, Amanda Blackford, Giovanni Parmigiani, Luis A Diaz, Nickolas Papadopoulos,[...]. Nat Genet 2013
274
14

Neuroblastoma.
Katherine K Matthay, John M Maris, Gudrun Schleiermacher, Akira Nakagawara, Crystal L Mackall, Lisa Diller, William A Weiss. Nat Rev Dis Primers 2016
378
14

A mechanistic classification of clinical phenotypes in neuroblastoma.
Sandra Ackermann, Maria Cartolano, Barbara Hero, Anne Welte, Yvonne Kahlert, Andrea Roderwieser, Christoph Bartenhagen, Esther Walter, Judith Gecht, Laura Kerschke,[...]. Science 2018
74
18

Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations.
Thomas F Eleveld, Derek A Oldridge, Virginie Bernard, Jan Koster, Léo Colmet Daage, Sharon J Diskin, Linda Schild, Nadia Bessoltane Bentahar, Angela Bellini, Mathieu Chicard,[...]. Nat Genet 2015
249
13

Neuroblastoma: developmental biology, cancer genomics and immunotherapy.
Nai-Kong V Cheung, Michael A Dyer. Nat Rev Cancer 2013
444
13

ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastoma.
Scott C Bresler, Daniel A Weiser, Peter J Huwe, Jin H Park, Kateryna Krytska, Hannah Ryles, Marci Laudenslager, Eric F Rappaport, Andrew C Wood, Patrick W McGrady,[...]. Cancer Cell 2014
189
12


Neuroblastoma.
John M Maris, Michael D Hogarty, Rochelle Bagatell, Susan L Cohn. Lancet 2007
11

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
11

Chromothripsis and Kataegis Induced by Telomere Crisis.
John Maciejowski, Yilong Li, Nazario Bosco, Peter J Campbell, Titia de Lange. Cell 2015
303
11

A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns.
Faiyaz Notta, Michelle Chan-Seng-Yue, Mathieu Lemire, Yilong Li, Gavin W Wilson, Ashton A Connor, Robert E Denroche, Sheng-Ben Liang, Andrew M K Brown, Jaeseung C Kim,[...]. Nature 2016
254
10

Advances in Risk Classification and Treatment Strategies for Neuroblastoma.
Navin R Pinto, Mark A Applebaum, Samuel L Volchenboum, Katherine K Matthay, Wendy B London, Peter F Ambros, Akira Nakagawara, Frank Berthold, Gudrun Schleiermacher, Julie R Park,[...]. J Clin Oncol 2015
323
10

Chromosome 1p and 11q deletions and outcome in neuroblastoma.
Edward F Attiyeh, Wendy B London, Yael P Mossé, Qun Wang, Cynthia Winter, Deepa Khazi, Patrick W McGrady, Robert C Seeger, A Thomas Look, Hiroyuki Shimada,[...]. N Engl J Med 2005
349
10

Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
Isabelle Janoueix-Lerosey, Delphine Lequin, Laurence Brugières, Agnès Ribeiro, Loïc de Pontual, Valérie Combaret, Virginie Raynal, Alain Puisieux, Gudrun Schleiermacher, Gaëlle Pierron,[...]. Nature 2008
573
9

Activating mutations in ALK provide a therapeutic target in neuroblastoma.
Rani E George, Takaomi Sanda, Megan Hanna, Stefan Fröhling, William Luther, Jianming Zhang, Yebin Ahn, Wenjun Zhou, Wendy B London, Patrick McGrady,[...]. Nature 2008
574
9

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.
Pauline Depuydt, Valentina Boeva, Toby D Hocking, Robrecht Cannoodt, Inge M Ambros, Peter F Ambros, Shahab Asgharzadeh, Edward F Attiyeh, Valérie Combaret, Raffaella Defferrari,[...]. J Natl Cancer Inst 2018
29
31


Altered telomeres in tumors with ATRX and DAXX mutations.
Christopher M Heaphy, Roeland F de Wilde, Yuchen Jiao, Alison P Klein, Barish H Edil, Chanjuan Shi, Chetan Bettegowda, Fausto J Rodriguez, Charles G Eberhart, Sachidanand Hebbar,[...]. Science 2011
623
9

Suppression of the alternative lengthening of telomere pathway by the chromatin remodelling factor ATRX.
David Clynes, Clare Jelinska, Barbara Xella, Helena Ayyub, Caroline Scott, Matthew Mitson, Stephen Taylor, Douglas R Higgs, Richard J Gibbons. Nat Commun 2015
128
9

Pan-cancer patterns of somatic copy number alteration.
Travis I Zack, Stephen E Schumacher, Scott L Carter, Andre D Cherniack, Gordon Saksena, Barbara Tabak, Michael S Lawrence, Cheng-Zhong Zhsng, Jeremiah Wala, Craig H Mermel,[...]. Nat Genet 2013
974
9

Chromosome catastrophes involve replication mechanisms generating complex genomic rearrangements.
Pengfei Liu, Ayelet Erez, Sandesh C Sreenath Nagamani, Shweta U Dhar, Katarzyna E Kołodziejska, Avinash V Dharmadhikari, M Lance Cooper, Joanna Wiszniewska, Feng Zhang, Marjorie A Withers,[...]. Cell 2011
278
9

Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.
G M Brodeur, R C Seeger, M Schwab, H E Varmus, J M Bishop. Science 1984
9

The landscape of genomic alterations across childhood cancers.
Susanne N Gröbner, Barbara C Worst, Joachim Weischenfeldt, Ivo Buchhalter, Kortine Kleinheinz, Vasilisa A Rudneva, Pascal D Johann, Gnana Prakash Balasubramanian, Maia Segura-Wang, Sebastian Brabetz,[...]. Nature 2018
436
9

Constitutional and somatic rearrangement of chromosome 21 in acute lymphoblastic leukaemia.
Yilong Li, Claire Schwab, Sarra Ryan, Elli Papaemmanuil, Hazel M Robinson, Patricia Jacobs, Anthony V Moorman, Sara Dyer, Julian Borrow, Mike Griffiths,[...]. Nature 2014
156
9

Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline.
Wigard P Kloosterman, Victor Guryev, Mark van Roosmalen, Karen J Duran, Ewart de Bruijn, Saskia C M Bakker, Tom Letteboer, Bernadette van Nesselrooij, Ron Hochstenbach, Martin Poot,[...]. Hum Mol Genet 2011
202
8

Chromothripsis and cancer: causes and consequences of chromosome shattering.
Josep V Forment, Abderrahmane Kaidi, Stephen P Jackson. Nat Rev Cancer 2012
217
8

Oncogenic mutations of ALK kinase in neuroblastoma.
Yuyan Chen, Junko Takita, Young Lim Choi, Motohiro Kato, Miki Ohira, Masashi Sanada, Lili Wang, Manabu Soda, Akira Kikuchi, Takashi Igarashi,[...]. Nature 2008
594
8

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.
Ruth Ladenstein, Ulrike Pötschger, Andrew D J Pearson, Penelope Brock, Roberto Luksch, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Geneviève Laureys, Josef Malis,[...]. Lancet Oncol 2017
142
8

Mutational dynamics between primary and relapse neuroblastomas.
Alexander Schramm, Johannes Köster, Yassen Assenov, Kristina Althoff, Martin Peifer, Ellen Mahlow, Andrea Odersky, Daniela Beisser, Corinna Ernst, Anton G Henssen,[...]. Nat Genet 2015
148
8

Overall genomic pattern is a predictor of outcome in neuroblastoma.
Isabelle Janoueix-Lerosey, Gudrun Schleiermacher, Evi Michels, Véronique Mosseri, Agnès Ribeiro, Delphine Lequin, Joëlle Vermeulen, Jérôme Couturier, Michel Peuchmaur, Alexander Valent,[...]. J Clin Oncol 2009
198
8

Activated ALK collaborates with MYCN in neuroblastoma pathogenesis.
Shizhen Zhu, Jeong-Soo Lee, Feng Guo, Jimann Shin, Antonio R Perez-Atayde, Jeffery L Kutok, Scott J Rodig, Donna S Neuberg, Daniel Helman, Hui Feng,[...]. Cancer Cell 2012
186
8

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.
Helena Carén, Hanna Kryh, Maria Nethander, Rose-Marie Sjöberg, Catarina Träger, Staffan Nilsson, Jonas Abrahamsson, Per Kogner, Tommy Martinsson. Proc Natl Acad Sci U S A 2010
129
8

Chromothripsis-like patterns are recurring but heterogeneously distributed features in a survey of 22,347 cancer genome screens.
Haoyang Cai, Nitin Kumar, Homayoun C Bagheri, Christian von Mering, Mark D Robinson, Michael Baudis. BMC Genomics 2014
70
11


A cell-based model system links chromothripsis with hyperploidy.
Balca R Mardin, Alexandros P Drainas, Sebastian M Waszak, Joachim Weischenfeldt, Mayumi Isokane, Adrian M Stütz, Benjamin Raeder, Theocharis Efthymiopoulos, Christopher Buccitelli, Maia Segura-Wang,[...]. Mol Syst Biol 2015
73
10

Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries.
Valentina Boeva, Caroline Louis-Brennetot, Agathe Peltier, Simon Durand, Cécile Pierre-Eugène, Virginie Raynal, Heather C Etchevers, Sophie Thomas, Alban Lermine, Estelle Daudigeos-Dubus,[...]. Nat Genet 2017
119
8

Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing.
Isidro Cortés-Ciriano, Jake June-Koo Lee, Ruibin Xi, Dhawal Jain, Youngsook L Jung, Lixing Yang, Dmitry Gordenin, Leszek J Klimczak, Cheng-Zhong Zhang, David S Pellman,[...]. Nat Genet 2020
103
8

Cancer: When catastrophe strikes a cell.
Jose M C Tubio, Xavier Estivill. Nature 2011
50
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.